EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Inhaled nucleic acid delivery systems for the treatment of pulmonary interstitial diseases: Challenges and opportunities

Jingwen Dong, Jiahui Chen, Junmei Mu, Yinuo Fan, Jinsu Wang, Qiyan Zhang, Lin Zhang, Zhanwei Zhou, Minjie Sun

Acta Pharmaceutica Sinica B · 2026-04 · 16 (4) · 2093-2118

DOI: 10.1016/j.apsb.2025.12.047 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-04. Verfasst von Jingwen Dong und 8 weiteren Autor:innen. Beteiligte Einrichtung: NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, State Key Laboratory of Natural Medicines, Department …. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 227 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, Jiangsu Provincial Key Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Anti-fibrosisAnti-inflammationImmune microenvironmentInhalationInterstitial lung diseasesRNA delivery systemRNA stabilityTargeted delivery system

Autor:innen und Institutionen

  • NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, Chi…

Förderung

  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Jiangsu Provincial Key Research and Development Program
  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Jiangsu Province
  • National Key Research and Development Program of China

Zitieren

APA

Dong, J., Chen, J., Mu, J., Fan, Y., Wang, J., Zhang, Q., Zhang, L., Zhou, Z., & Sun, M. (2026). Inhaled nucleic acid delivery systems for the treatment of pulmonary interstitial diseases: Challenges and opportunities. Acta Pharmaceutica Sinica B, 16(4), 2093-2118. https://doi.org/10.1016/j.apsb.2025.12.047

Vancouver

Dong J, Chen J, Mu J, Fan Y, Wang J, Zhang Q, et al. Inhaled nucleic acid delivery systems for the treatment of pulmonary interstitial diseases: Challenges and opportunities. Acta Pharmaceutica Sinica B. 2026;16(4):2093-2118. doi:10.1016/j.apsb.2025.12.047

BibTeX
@article{Dong2026,
  author = {Dong, Jingwen and Chen, Jiahui and Mu, Junmei and Fan, Yinuo and Wang, Jinsu and Zhang, Qiyan and Zhang, Lin and Zhou, Zhanwei and Sun, Minjie},
  title = {Inhaled nucleic acid delivery systems for the treatment of pulmonary interstitial diseases: Challenges and opportunities},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  volume = {16},
  number = {4},
  pages = {2093--2118},
  doi = {10.1016/j.apsb.2025.12.047}
}
Kostenlos starten →